The Danish Medicines Verification System (DMVS) is a central part of the FMD framework and serves as the technical solution that supports the verification of medicines in Denmark. As a national competent authority (NCA), the Danish Medicines Agency has access to reporting functions in the DMVS that allow for:

Incident and alert insights
Access to detailed data about alerts, including causes, frequency, and handling. This makes it possible to identify patterns and respond proactively to potential risks in the supply chain.

Data for analysis and compliance
Reports support the authorities’ work to ensure compliance with FMD regulations. Data can be used to assess the behaviors of stakeholders, identify deviations and document compliance with EU requirements.

System performance monitoring
Gain insight into system stability, response times, and transaction volume. This provides a clear picture of how DMVS works in practice and ensures that any technical challenges can be addressed quickly.

If you work at the Danish Medicines Agency, you are welcome to contact the Danish Medicine Verification Organisation for further introduction and training in the reporting options available in the system.